SCHEMBL22606319

SCHEMBL22606319

C/C(N)=N\C(=N)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 1/20 0.50
▸ F10 P00742 1/20 0.50
▸ F12 P00748 1/20 0.50
▸ F7 P08709 1/20 0.50
▸ F3 P13726 1/20 0.50
▸ PKM P14618 1/20 0.50
▸ BLM P54132 2/20 0.48
▸ NOS1 P29475 4/20 0.46
▸ NOS3 P29474 3/20 0.46
▸ PRSS1 P07477 2/20 0.46
▸ PRSS2 P07478 2/20 0.46
▸ PRSS3 P35030 2/20 0.46
▸ RECQL P46063 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ C1S P09871 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ METTL3 Q86U44 1/20 0.40
▸ ESR1 P03372 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18561043 0.82 PRSS1 (0.50) F2F10NOS1PRSS1PRSS2
SCHEMBL22744840 0.82 F2 (0.42) F2F10F12F7F3
SCHEMBL17117437 0.80 LMNA (0.45) F2F10F12F7F3
SCHEMBL10252853 0.80 F2 (0.52) F2F10F12F7F3
SCHEMBL22882157 0.78 F2 (0.50) F2F10F12F7F3
SCHEMBL2669047 0.78 F2 (0.39) F2F10F12F7F3
SCHEMBL17400227 0.78 F2 (0.39) F2F10F12F7F3
SCHEMBL23759891 0.78 F2 (0.45) F2F10F12F7F3
SCHEMBL22596711 0.78 F2 (0.45) F2F10F12F7F3
SCHEMBL23106224 0.77 F7 (0.50) F7F3PKMKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3967691-A1 PYRIMIDO FIVE-MEMBERED HETEROCYCLIC COMPOUND AND USE THEREOF AS MUTANT IDH2 INHIBITOR Epitas Biosciences (Shanghai) Co., Ltd. (CN) 2022-03-16 — — EP disclosed
WO-2020215998-A1 PYRIMIDO FIVE-MEMBERED HETEROCYCLIC COMPOUND AND USE THEREOF AS MUTANT IDH2 INHIBITOR 上海仕谱生物科技有限公司 2020-10-29 — — WO disclosed
Send feedback